The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs

Hensel, N; Kubinski, S; Claus, P

Claus, P (corresponding author), Hannover Med Sch, Inst Neuroanat & Cell Biol, Hannover, Germany.; Claus, P (corresponding author), Ctr Syst Neurosci ZSN, Hannover, Germany.

FRONTIERS IN NEUROLOGY, 2020; 11 ():

Abstract

Spinal Muscular Atrophy (SMA) is monogenic motoneuron disease caused by low levels of the Survival of Motoneuron protein (SMN). Recently, two differen......

Full Text Link